J0638 Canakinumab injection
J-Codes
Also known as: canakinumab, Ilaris, IL-1 beta antagonist
Canakinumab injection, a monoclonal antibody against interleukin-1 beta for treatment of cryopyrin-associated periodic syndromes and gout.
Clinical Context
Monoclonal antibody targeting interleukin-1 beta, indicated for cryopyrin-associated periodic syndromes (CAPS), familial Mediterranean fever, and acute gout attacks.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.